Paul Cox | IR |
Jeffrey Jonas | CEO, President & Director |
Stephen Kanes | Chief Medical Officer |
Michael Cloonan | Chief Business Officer |
Kimi Iguchi | CFO & Treasurer |
Jim Doherty | SVP, Research |
Brian Abrahams | RBC Capital Markets |
Paul Matteis | Leerink Partners |
Vikram Purohit | Morgan Stanley |
Tazeen Ahmad | Bank of America Merrill Lynch |
Salveen Richter | Goldman Sachs Group |
Laura Chico | Raymond James & Associates |
Danielle Brill | Piper Jaffray Companies |
Shawn Fu | JPMorgan Chase & Co. |
Myles Minter | William Blair & Company |
Michael Higgins | Ladenburg Thalmann & Co. |
Good morning, and welcome to Sage Therapeutics' Second Quarter 2018 Financial Results Conference Call. [Operator Instructions]. This call is being webcast live on the Investors & Media section of Sage's website at sagerx.com. This call is a property of Sage Therapeutics and recordings, reproductions or transmission of this call without the express written consent of Sage Therapeutics is strictly prohibited. Please note this call is being recorded.